1. Home
  2. GROV vs MYO Comparison

GROV vs MYO Comparison

Compare GROV & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.09

Market Cap

52.1M

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.07

Market Cap

44.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
MYO
Founded
2016
2004
Country
United States
United States
Employees
295
N/A
Industry
Package Goods/Cosmetics
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.1M
44.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
GROV
MYO
Price
$1.09
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$1.60
$7.67
AVG Volume (30 Days)
33.7K
317.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
$6.81
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$1.05
$0.61
52 Week High
$1.60
$2.02

Technical Indicators

Market Signals
Indicator
GROV
MYO
Relative Strength Index (RSI) 45.34 51.71
Support Level $1.07 $0.89
Resistance Level $1.33 $1.17
Average True Range (ATR) 0.07 0.09
MACD 0.00 0.01
Stochastic Oscillator 41.67 73.07

Price Performance

Historical Comparison
GROV
MYO

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: